12 completed, 2 recruiting, 1 not yet recruiting, 1 suspended. 6 Phase 2, 4 Not applicable, 4 Phase 3, 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Suspended 1 |
| Not applicable | 4 | Completed 3, Not yet recruiting 1 |
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow Common Wart: new trials by email Literature Review of Common Wart trials Research Report on Common Wart
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir Intralesional Acyclovir, Intralesional Vitamin D3 - Viral Wart, Plantar Wart | Phase 4 | Recruiting | Riphah International University | 40 | 2026-02-20 | 2026-08-07 |
| Sclerotherapy and Candida Antigen in Treatment of Common Warts polidacanol 3%, candida antigen - Common Wart | Not applicable | Not yet recruiting | Sohag University | 75 | 2024-12-20 | 2024-12-27 |
| Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. Sérum VERRUPRO - Warts, Plantar Wart | Not applicable | Completed | Swiss Footcare Laboratories - Poderm Professional | 33 | 2024-02-19 | 2025-03-05 |
| OM202JP Clinical Study of KNP2002 KNP2002, Placebo of KNP2002 - Common Wart | Phase 2 | Completed | KinoPharma Inc. | 159 | 2023-06-12 | 2024-09-27 |
| Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts VDMN-21 Patch Low Dose, VDMN-21 Patch High Dose, Vehicle Patch - Verruca Vulgaris, Warts | Phase 2 | Completed | Veradermics, Inc. | 153 | 2023-02-28 | 2025-05-08 |
| Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts Wortie freeze plus - Common Wart, Plantar Wart | Not applicable | Completed | Karo Pharma AB | 50 | 2021-10-12 | 2023-02-21 |
| Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts Tuberculin purified protein derivative - Common Wart | Phase 3 | Unknown | Assiut University | 40 | 2020-03-01 | 2020-02-28 |
| Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts 2LVERU® or 2LVERU® JUNIOR, Placebo - Common Wart, Flat Wart | Phase 4 | Recruiting | Labo'Life | 162 | 2020-02-17 | 2026-08-31 |
| Safety Study of A-101 Topical Solution for the Treatment of Common Warts A-101 - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 426 | 2019-02-07 | 2020-11-23 |
| Study of A-101 Topical Solution for the Treatment of Common Warts A-101, vehicle - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 503 | 2018-09-17 | 2020-10-05 |
| A Study of A-101 Topical Solution for the Treatment of Common Warts Active, Vehicle - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 502 | 2018-09-13 | 2020-10-27 |
| Cantharidin and Occlusion in Verruca Epithelium VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin, topical film forming solution - Common Wart, Warts Hand | Phase 2 | Completed | Verrica Pharmaceuticals Inc. | 56 | 2018-03-27 | 2024-11-27 |
| A Phase2 of A-101 Topical Solution in Subjects With Common Warts A-101 Topical Solution, A-101 Vehicle Solution - Common Wart | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 157 | 2017-08-01 | 2019-05-01 |
| Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Measles-Mumps-Rubella Vaccine, cryotherapy - Common Wart, Plantar Wart | Phase 4 | Completed | Assiut University | 48 | 2017-08-01 | 2020-06-16 |
| A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts A-101 Topical Solution, A-101 Vehicle Solution - Common Wart | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 159 | 2017-07-13 | 2019-04-09 |
| Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts duct tape occlusion therapy - Wart, Common Wart | Not applicable | Completed | Minneapolis Veterans Affairs Medical Center | 90 | 2004-10-01 | 2006-05-24 |
Warts (17) · DNA Virus Infections (1) · Papillomavirus Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Viral (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Infections (17) · Skin and Connective Tissue Diseases (17) · DNA Virus Infections (16) · Papillomavirus Infections (16) · Skin Diseases (16) · Skin Diseases, Infectious (16) · Skin Diseases, Viral (16) · Tumor Virus Infections (16) · Virus Diseases (16) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1)
2-Propanol (2) · N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (2) · Cryotherapy (1) · Exercise (1) · Measles-Mumps-Rubella Vaccine (1) · PRA1 protein, Candida albicans (1) · Tuberculin (1)
Aclaris Therapeutics, Inc. (5) · Assiut University (2) · G&E Herbal Biotechnology Co., LTD (1) · Karo Pharma AB (1) · KinoPharma Inc. (1) · Labo'Life (1) · Minneapolis Veterans Affairs Medical Center (1) · Riphah International University (1) · Sohag University (1) · Swiss Footcare Laboratories - Poderm Professional (1) · Veradermics, Inc. (1) · Verrica Pharmaceuticals Inc. (1)
United States (8) · Egypt (2) · Belgium (1) · Japan (1) · Pakistan (1) · Poland (1) · Tunisia (1)
Adnan Nasir, MD (1) · Agnieszka Cegielska, MD (1) · David Gordon, MB, ChB (1) · Erin M. Warshaw, MD (1) · Fatima Sajid, FCPS (1) · Hamm-Ming Sheu, MD (1) · Judy Schynder (1) · Kou-Wha Kuo, Ph.D (1) · Scott Guenthner, MD (1) · Stuart D Shanler, MD (1)